Description

Buy defence blend Mushrooms

With our Defence Blend, you can strengthen both your body and mind.
This potent immune support, which contains turkey tail, reishi, elderflower, turmeric, and astragalus, will be your finest defense against the world.

Ingredients Per capsule:

• Forest Blend (Psilocybe Cubensis) – 200mg
  Bacopa Monnier – 75mg
  Citicoline – 75mg
  L-Tyrosine – 75mg
  5-HTP – 75mg
• How to order

What is Microdosing psychedelics?

is the practice of taking very small amounts of a psychedelic substance, such as lysergic acid diethylamide (LSD) or psilocybin-containing mushrooms, in order to get sub-hallucinogenic effects. Microdosing has gained in popularity, according to media accounts, however there is little research on the subject in the scholarly literature. Microdosers’ experiences in community samples have not been characterized, and there has been limited reporting on adverse outcomes linked with microdosing.

The advantages of taking full-dose psychedelics

While over a thousand early studies linked psychedelic use to positive outcomes [12], there was a 40-year hiatus in psychedelic research after its criminalization [13]. Despite their continued prohibition, modern research has revealed LSD and psilocybin’s promising potential for treating alcohol and tobacco addiction [14,15,16,17], depression [18, 19], and end-of-life anxiety [20,21,22], as well as related research on 3,4-methylenedioxymethamphetamine (MDMA) for treating post-traumatic stress disorder [23]. In healthy controls, psychedelics can also promote openness and cause mystical-type experiences [24,25,26]. Because full-dose psychedelics appear to help with the treatment of severe, chronic psychiatric illnesses (e.g. depression, anxiety, PTSD), lower, recurrent doses could be used to treat milder mental health issues. This is particularly important to examine if some full-dose effects are discovered to be predominantly based on pharmacologic mechanisms rather than phenomenological experiences [27].Limiting microdosing research to issues that have already been studied in full-dose research risks overlooking unexpected and perhaps different microdosing outcomes. Full-dose research has used a variety of focal assessments of symptomatology, mood, and personality that are likely applicable to microdosing research, but other full-dose phenomena, such as ego dissolution and mystical-type experiences, are less relevant to microdosing research due to the low doses and lack of perceptual alteration intended in microdosing.